Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1839077rdf:typepubmed:Citationlld:pubmed
pubmed-article:1839077lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:1839077lifeskim:mentionsumls-concept:C0008109lld:lifeskim
pubmed-article:1839077lifeskim:mentionsumls-concept:C0025914lld:lifeskim
pubmed-article:1839077lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:1839077lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:1839077lifeskim:mentionsumls-concept:C1155046lld:lifeskim
pubmed-article:1839077lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:1839077pubmed:issue9lld:pubmed
pubmed-article:1839077pubmed:dateCreated1992-4-9lld:pubmed
pubmed-article:1839077pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1839077pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1839077pubmed:abstractTextThe isotype of anti-CD3 mAb has a dramatic effect on anti-CD3 induced T-cell activation, as was previously reported for switch variants (IgG2b to IgA) of a high-avidity IgG1 anti-CD3 mAb (CLB-T3/4.1). In order to study and compare the isotype dependency of T-cell activation with anti-CD3 mAb of various mouse and human subclasses, we now prepared recombinant anti-CD3 mAb. The variable region of the anti-CD3 Ig heavy chain was cloned, joined with genes for the heavy chain constant region and expressed in a cell line only secreting autologous mouse chi light chains. Thus we obtained cell lines that produced mouse (m) IgM, mIgG3 and chimaeric mouse/human (h) IgM, hlgG1, hlgG2, hlgG3, hlgG4, hlgE and hlgA2 anti-CD3. The matched set of mouse and mouse/human chimaeric anti-CD3 isotypes switch variants was then used to study activation of T cells in an accessory cell-dependent system. hlgG1, hlgG4, hlgE, mlgG2a and mlgE induced T-cell proliferation in PBMC of all donors tested, whereas PBMC from a subset of donors were unresponsive to stimulation with hlgG2, hlgG3, hlgA2, mlgG1 and mlgG2b anti-CD3 mAb. hlgM, mlgM and mlgA were only able to induce T-cell mitogenesis in combination with PMA. Our panel of anti-CD3 mAb variants may prove a powerful tool to study mouse and human isotype-dependent effector functions and their influence on T-cell activation requirements in detail.lld:pubmed
pubmed-article:1839077pubmed:languageenglld:pubmed
pubmed-article:1839077pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1839077pubmed:citationSubsetIMlld:pubmed
pubmed-article:1839077pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1839077pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1839077pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1839077pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1839077pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1839077pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1839077pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1839077pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1839077pubmed:statusMEDLINElld:pubmed
pubmed-article:1839077pubmed:issn0923-2494lld:pubmed
pubmed-article:1839077pubmed:authorpubmed-author:AardenL ALAlld:pubmed
pubmed-article:1839077pubmed:authorpubmed-author:PatteeLLlld:pubmed
pubmed-article:1839077pubmed:authorpubmed-author:BoeijeL CLClld:pubmed
pubmed-article:1839077pubmed:authorpubmed-author:GeertsM EMElld:pubmed
pubmed-article:1839077pubmed:issnTypePrintlld:pubmed
pubmed-article:1839077pubmed:volume142lld:pubmed
pubmed-article:1839077pubmed:ownerNLMlld:pubmed
pubmed-article:1839077pubmed:authorsCompleteYlld:pubmed
pubmed-article:1839077pubmed:pagination749-63lld:pubmed
pubmed-article:1839077pubmed:dateRevised2005-11-17lld:pubmed
pubmed-article:1839077pubmed:meshHeadingpubmed-meshheading:1839077-...lld:pubmed
pubmed-article:1839077pubmed:meshHeadingpubmed-meshheading:1839077-...lld:pubmed
pubmed-article:1839077pubmed:meshHeadingpubmed-meshheading:1839077-...lld:pubmed
pubmed-article:1839077pubmed:meshHeadingpubmed-meshheading:1839077-...lld:pubmed
pubmed-article:1839077pubmed:meshHeadingpubmed-meshheading:1839077-...lld:pubmed
pubmed-article:1839077pubmed:meshHeadingpubmed-meshheading:1839077-...lld:pubmed
pubmed-article:1839077pubmed:meshHeadingpubmed-meshheading:1839077-...lld:pubmed
pubmed-article:1839077pubmed:meshHeadingpubmed-meshheading:1839077-...lld:pubmed
pubmed-article:1839077pubmed:meshHeadingpubmed-meshheading:1839077-...lld:pubmed
pubmed-article:1839077pubmed:meshHeadingpubmed-meshheading:1839077-...lld:pubmed
pubmed-article:1839077pubmed:meshHeadingpubmed-meshheading:1839077-...lld:pubmed
pubmed-article:1839077pubmed:meshHeadingpubmed-meshheading:1839077-...lld:pubmed
pubmed-article:1839077pubmed:meshHeadingpubmed-meshheading:1839077-...lld:pubmed
pubmed-article:1839077pubmed:meshHeadingpubmed-meshheading:1839077-...lld:pubmed
pubmed-article:1839077pubmed:meshHeadingpubmed-meshheading:1839077-...lld:pubmed
pubmed-article:1839077pubmed:meshHeadingpubmed-meshheading:1839077-...lld:pubmed
pubmed-article:1839077pubmed:meshHeadingpubmed-meshheading:1839077-...lld:pubmed
pubmed-article:1839077pubmed:meshHeadingpubmed-meshheading:1839077-...lld:pubmed
pubmed-article:1839077pubmed:meshHeadingpubmed-meshheading:1839077-...lld:pubmed
pubmed-article:1839077pubmed:meshHeadingpubmed-meshheading:1839077-...lld:pubmed
pubmed-article:1839077pubmed:articleTitleInduction of T-cell proliferation by recombinant mouse and chimeric mouse/human anti-CD3 monoclonal antibodies.lld:pubmed
pubmed-article:1839077pubmed:affiliationCentral Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam.lld:pubmed
pubmed-article:1839077pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1839077lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1839077lld:pubmed